Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologySuppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapyNpr2, yeast homolog of the human tumor suppressor NPRL2, is a target of Grr1 required for adaptation to growth on diverse nitrogen sources.The role of p53 in cancer drug resistance and targeted chemotherapyNon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipSky1 regulates the expression of sulfur metabolism genes in response to cisplatinCisplatin and aminoglycoside antibiotics: hearing loss and its prevention.WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer.Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis.Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cellsAdenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistanceEpidemiology of lung cancer prognosis: quantity and quality of life.Effects of cisplatin on the contractile function of thoracic aorta of Sprague-Dawley rats.Heterogeneity of excision repair cross-complementation group 1 gene expression in non-small-cell lung cancer patients.Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary cultureChemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancerVasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.Enzymatic processing of platinated RNAs.Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic AgentsApoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cellsPotentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model.Comparison of the efficacy among multiple chemotherapeutic interventions combined with radiation therapy for patients with cervix cancer after surgery: A network meta-analysis.Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor AgentsThe Current and Future Therapies for Human Osteosarcoma.Ethanol and vitamin D receptor in T cell apoptosis.Effects of oxaliplatin on mouse myenteric neurons and colonic motility.Repopulation of ovarian cancer cells after chemotherapyMitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.Cytoplasmic initiation of cisplatin cytotoxicity.Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts.Deficit of p66ShcA restores redox-sensitive stress response program in cisplatin-induced acute kidney injury.RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insultNovel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment.Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity.Pentamidine reverses the splicing defects associated with myotonic dystrophy.
P2860
Q21129303-8E98DA66-CDCD-441C-84FB-CB5F9894EDCFQ24631616-16D68210-F7FA-4C8B-9261-5F584B1AE226Q27929831-4D4208A7-4397-4498-B592-BB613315FB05Q28072553-2B0EEC00-BD09-4BF5-B880-8CCDACC67313Q28278682-7B269EFF-CF10-4800-82B2-0917688ADA27Q28389083-959249B1-19E6-4A4C-95D1-1891DF588427Q30447637-D924FC8F-6964-40D6-AF2D-626DB28B453EQ30492649-C8587CF5-1346-441C-99B9-CFA64D5645A6Q33554403-9373A39B-24DC-41CB-82AC-3D91E9F446B8Q33737209-DF3A09D4-5E4D-495D-91CF-D25C06AFD954Q33800218-92D2515C-2A51-499E-B412-153E10E99549Q33941309-D44D0A71-1153-43C1-985A-EA11CDE37DE1Q34135295-8F23B4BA-6AC4-4E8C-8682-BAD89B9C6577Q34265605-ABFB87A2-66B5-4BBA-AE88-9B3C19E1EE6DQ34607731-410DBEDD-8627-4CC8-A107-1C70458DA799Q34619471-96FA603F-34DE-4859-8D0B-F495ADD0F538Q34849073-4C666769-3399-41F2-86CA-E381F43CCFAFQ35111116-62490FFA-4D60-4440-AC19-2ED65FA8A219Q35591417-3685203A-88E1-4463-9F03-35068AB81CA5Q35692141-88484443-2F6C-4253-842B-AB202CFDE6A2Q35990617-A0B9C419-4FC8-4677-8321-8A104211F186Q36036927-29DCC0D2-9977-4A49-B035-856D190CACF3Q36359692-EBCBAF7C-F247-4813-8349-4E808E36B991Q36363546-876E58CD-5B41-4301-B6B2-B6DF7F28DAB2Q36372357-0BA1D5C9-4FC1-4C19-B2A1-AABD3F7B2ACCQ36465031-CA774E76-4AE6-4155-9F6E-3607736ABFAEQ36514299-AD2A6938-B148-43C5-9721-61CC83BD0984Q36565937-03967557-F921-413B-B0B0-3C4ABBBBB4C2Q36676211-5C7D6AC8-4BE8-47F2-B4C4-3C9DE1C7C218Q36725453-BB0DA08C-38AF-45CD-9128-1ECC4DB7CC0AQ36743607-DF10E04D-75F0-4DBF-ABF4-F52B8CCBE7A6Q36807108-F3FE5420-6F0F-46A4-958A-799C8785A838Q36817080-73FB1723-04F2-48C1-A5C9-25B28F188DBFQ36883608-4C9620AD-D0F8-4B87-BEC6-F0AB1742BF9DQ37037701-57A48795-E0C8-4EFE-B756-5683D800B476Q37067521-EF5B3CA4-52B5-4044-ADC2-5A67464635ACQ37139330-30675A65-BA65-4AFE-840A-2DBC8FCD3163Q37200444-2FDF128B-2445-463C-BF64-43C327A87735Q37259459-F041AF62-474F-45DC-8EFE-A38EDFA5EBBAQ37413602-56094014-7C7F-43FD-A417-9CA7C1C9D01B
P2860
Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cisplatin biochemical mechanis ...... optotic and necrotic pathways.
@ast
Cisplatin biochemical mechanis ...... optotic and necrotic pathways.
@en
type
label
Cisplatin biochemical mechanis ...... optotic and necrotic pathways.
@ast
Cisplatin biochemical mechanis ...... optotic and necrotic pathways.
@en
prefLabel
Cisplatin biochemical mechanis ...... optotic and necrotic pathways.
@ast
Cisplatin biochemical mechanis ...... optotic and necrotic pathways.
@en
P2093
P356
P1476
Cisplatin biochemical mechanis ...... optotic and necrotic pathways.
@en
P2093
P304
P356
10.2174/0929867033368484
P577
2003-02-01T00:00:00Z